Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the¶ most important products for the treatment of arthritis. It is well tolerated and has a lo​w incidence of side effects

key word:

non-steroidal ketoprofen

Category:

Consulting
Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large health in÷dustry finance platform company integrating pharmaceutical, intelligent med↑ical, bio pharmaceutical R&D, industrial production and sales.

The chemical reactions involved in the existing products include Foucault ↑reaction, nitration reaction, sulfonation reaction, hydrogenation reactiλon, fluorination reaction, chlorination reaction, bromination react↑ion, diazotization reaction, format reaction, etc.

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important pr÷oducts for the treatment of arthritis. It is well tolerated and h→as a low incidence of side effects

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed by Mer×ck. In October 2006, Sitagliptin phosphate Januvia was approved by FDA as th™e first DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The characteristics of this★ drug are that it can stimulate insulin secretion while reducing hunger without causing wεeight gain. Hypoglycemia and edema will not occur, and it is suitable for diabetic patients w↑ith poor blood glucose control and frequent hypoglγycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmac≥eutical enterprise that is market-oriented and realizes industrial developmen₽t through R&D innovation and technology transformati×on.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most im→portant products for the treatment of arthritis. It is well tolerated and has a low inc&idence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukoσtriene receptor antagonists. In clinical application‌, it has good therapeutic effect on atopic asthma and other types of bronchial  asthma, and the market prospect is huge. In the major€ category of asthma drugs, leukotriene receptor antagonists have the fastest γgrowing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is maσrket-oriented and realizes industrial development through R&D innovation and technology ←transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug a≈pproved by FDA for Alzheimer's disease in the United St'ates. Its treatment reaches the target dose and has low toxic and si de effects. It has been widely recognized by our medical commun ity, and good tolerance is its biggest advantage. In October 1999, Donepezil wa¶s launched in China under the trade name "Aricept", which is the main chemical dru€g against Alzheimer's disease. At present, CFDA has approλved a number of domestic enterprises to produce donepezil preparations, the main dosage forms are ®tablets, capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, B♦ristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was approved for use in the 27Ω EU member states. The world's first drug approved to prevent venous thromboembolism (VTE) in adultσ patients undergoing elective hip or knee replacement. From June 2019 to June 2020,€ the annual sales of apixaban products overseas reached about $15.4 billion, with a< year-on-year growth of nearly 32%, and the API consumption reached about 23,96✔0 kg, with a year-on-year growth of about 28%. Compared with its main competitor, Rivaroxaban,↕ the drug's annual overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that§ is market-oriented and realizes industrial development through R&D innoπvation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzym☆e. On December 29, 2004, it was approved by FDA for the treatment of refractory or r elapsed acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is m↔arket-oriented and realizes industrial development through R&D innovat∏ion and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other serv≤ices, E-mail: 2880705932@qq.com

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.